相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors
Pamela Nicholson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
In vitro readthrough of termination codons by gentamycin in the Stuve-Wiedemann Syndrome
Samuel Bellais et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons
Alona Zilberberg et al.
GUT (2010)
Therapeutic targeting of p53 by small molecules
Galina Selivanova
SEMINARS IN CANCER BIOLOGY (2010)
Targeting p53 for novel anticancer therapy
Zhen Wang et al.
TRANSLATIONAL ONCOLOGY (2010)
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients
Francesca Salvatori et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases Progress in Development
Steven M. Rowe et al.
BIODRUGS (2009)
Poly-L-aspartic Acid Enhances and Prolongs Gentamicin-mediated Suppression of the CFTR-G542X Mutation in a Cystic Fibrosis Mouse Model
Ming Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Recognition of nonsense mRNA: towards a unified model
Oliver Muhlemann
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells
R. Magrini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Drug-induced readthrough of premature stop codons leads to the stabilization of laminin α2 chain mRNA in CMD myotubes
Valerie Allamand et al.
JOURNAL OF GENE MEDICINE (2008)
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
Ming Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Aminoglycoside induced ototoxicity
O'neil W. Guthrie
TOXICOLOGY (2008)
Introducing sense into nonsense in treatments of human genetic diseases
Liat Linde et al.
TRENDS IN GENETICS (2008)
CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice
Xiuwei Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin
Chunmei Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis:: a pilot study
Isabelle Sermet-Gaudelus et al.
BMC MEDICINE (2007)
Aminoglycoside-induced translational read-through in disease: Overcoming nonsense mutations by pharmacogenetic therapy
L. V. Zingman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges
Holly A. Kuzmiak et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Adenovirus p53 gene therapy
JA Roth
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C
K Takamoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers
ZH Peng
HUMAN GENE THERAPY (2005)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S-cerevisiae
KM Keeling et al.
RNA (2004)
Readthrough of dystrophin stop codon mutations induced by aminoglycosides
MT Howard et al.
ANNALS OF NEUROLOGY (2004)
The role of p53 in chemosensitivity and radiosensitivity
WS El-Deiry
ONCOGENE (2003)
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
M Wilschanski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system
KM Keeling et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis
JP Clancy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Establishment and characterization of a new cell line derived from a human primary breast carcinoma
CS Wang et al.
CANCER GENETICS AND CYTOGENETICS (2000)
Nonsense-mediated decay mutants do not affect programmed-1 frameshifting
L Bidou et al.
RNA (2000)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
分享论文
